menu
    • menu

    Company profile for Ethris

    NEW Drugs in Dev: 5
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Based in the biotech hub of Martinsried just outside Munich, Germany, Ethris was founded by Dr. Carsten Rudolph and Prof. Christian Plank in 2009 to develop messenger RNA as a new drug modality. The company’s focus is to develop products based on its’ proprietary SNIM®RNA technology to treat patients with respiratory disorders. Ethris has developed a pipeline of Transcript Therapies for rare and genetic respiratory diseas...
    Based in the biotech hub of Martinsried just outside Munich, Germany, Ethris was founded by Dr. Carsten Rudolph and Prof. Christian Plank in 2009 to develop messenger RNA as a new drug modality. The company’s focus is to develop products based on its’ proprietary SNIM®RNA technology to treat patients with respiratory disorders. Ethris has developed a pipeline of Transcript Therapies for rare and genetic respiratory diseases, and is working with partners to advance programs for other respiratory diseases and for non-respiratory conditions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EthrisGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Semmelweisstr. 3 82152 Planegg
    Telephone
    Telephone
    +49-(0)-89-89 55 788 0
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ethris.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ethris In Consortium Getting EUR 148M Eu Commission Contract
    Ethris In Consortium Getting EUR 148M Eu Commission Contract

    25 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/25/3244266/0/en/Ethris-Part-of-Consortium-to-Receive-up-to-EUR-148-Million-European-Commission-Contract-to-Advance-Novel-Pandemic-Influenza-Vaccine.html

    GLOBENEWSWIRE
    25 Feb 2026
    Share Share
    Ethris, (DZIF) Partner To Develop Mrna Vaccines
    Ethris, (DZIF) Partner To Develop Mrna Vaccines

    09 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-09/ethris-and-german-center-for-infection-research-dzif-announce-strategic-collaboration-to-develop-m

    PHARMIWEB
    09 Feb 2026
    Share Share
    Evonik, Ethris Partner to Broaden Nucleic Acid Delivery Options
    Evonik, Ethris Partner to Broaden Nucleic Acid Delivery Options

    09 Sep 2025

    // PRESS RELEASE

    https://www.evonik.com/en/news/press-releases/2025/09/evonik-and-ethris-enter-strategic-partnership-to-expand-offerings-for-nucleic-acid-delivery.html

    PRESS RELEASE
    09 Sep 2025
    Share Share
    Ethris Begins Phase 2a Trial of mRNA Candidate ETH47 for Asthma
    Ethris Begins Phase 2a Trial of mRNA Candidate ETH47 for Asthma

    05 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250805027802/en/Ethris-Doses-First-Patient-in-Phase-2a-Clinical-Trial-of-Lead-mRNA-Candidate-ETH47-for-Asthma

    BUSINESSWIRE
    05 Aug 2025
    Share Share
    Ethris Collaborates with Thermo Fisher for mRNA Tech Access
    Ethris Collaborates with Thermo Fisher for mRNA Tech Access

    13 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250613204514/en/Ethris-Signs-Strategic-Collaboration-with-Thermo-Fisher-Scientific-to-Provide-Access-to-mRNA-Technology-Platforms

    BUSINESSWIRE
    13 Jun 2025
    Share Share
    Ethris Gets €10M EU4Health Grant for mRNA Candidate ETH47
    Ethris Gets €10M EU4Health Grant for mRNA Candidate ETH47

    06 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250506252013/en/Ethris-Receives-%E2%82%AC10-Million-EU4Health-Grant-to-Support-Clinical-Development-and-Expand-Antiviral-Applications-of-Lead-mRNA-Candidate-ETH47

    BUSINESSWIRE
    06 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search